Century Therapeutics, Inc. (IPSC)
Market Open
15 Jun, 15:20
NASDAQ (NGS) NASDAQ (NGS) Primary $
2. 31
+0.06
+2.84%
$
194.78M Market Cap
- P/E Ratio
- Div Yield
179,565 Volume
-2.04 Eps
$ 2.25
Previous Close 
Want to track IPSC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.17 | 0.89 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
IPSC Earnings Reports FAQ
What is the earnings per share (EPS) for IPSC?
The current EPS is -2.04.
What is the company's earnings growth rate?
Century Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Century Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Century Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for IPSC at this time, as Century Therapeutics, Inc has no recent EPS data to calculate it.
